Smart Eye AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009268279
SEK
71.20
1.15 (1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Mar 25

  • NET PROFIT(HY) At SEK -120.93 MM has Grown at -251.36%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 7.79%
  • RAW MATERIAL COST(Y) Grown by 10.39% (YoY)
2

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 2,968 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

-15.27%

stock-summary
Price to Book

2.13

Revenue and Profits:
Net Sales:
92 Million
(Quarterly Results - Jun 2025)
Net Profit:
-37 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.06%
0%
-11.06%
6 Months
3.04%
0%
3.04%
1 Year
11.95%
0%
11.95%
2 Years
9.88%
0%
9.88%
3 Years
44.69%
0%
44.69%
4 Years
-55.84%
0%
-55.84%
5 Years
-54.13%
0%
-54.13%

Smart Eye AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
44.53%
EBIT Growth (5y)
-170.81%
EBIT to Interest (avg)
-134.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.20
Tax Ratio
10.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.31
EV to EBIT
-14.70
EV to EBITDA
-63.71
EV to Capital Employed
2.22
EV to Sales
9.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-15.09%
ROE (Latest)
-15.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 2.79% vs 30.23% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 31.00% vs 20.99% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.10",
          "val2": "89.60",
          "chgp": "2.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.30",
          "val2": "-23.10",
          "chgp": "118.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "0.20",
          "chgp": "1,650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-37.40",
          "val2": "-54.20",
          "chgp": "31.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-404.50%",
          "val2": "-714.00%",
          "chgp": "30.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.47% vs 37.68% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -205.17% vs 77.81% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "355.00",
          "val2": "302.20",
          "chgp": "17.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-82.70",
          "val2": "-132.30",
          "chgp": "37.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "2.30",
          "chgp": "91.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-230.40",
          "val2": "-75.50",
          "chgp": "-205.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-706.10%",
          "val2": "-951.30%",
          "chgp": "24.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
92.10
89.60
2.79%
Operating Profit (PBDIT) excl Other Income
4.30
-23.10
118.61%
Interest
3.50
0.20
1,650.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-37.40
-54.20
31.00%
Operating Profit Margin (Excl OI)
-404.50%
-714.00%
30.95%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 2.79% vs 30.23% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 31.00% vs 20.99% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
355.00
302.20
17.47%
Operating Profit (PBDIT) excl Other Income
-82.70
-132.30
37.49%
Interest
4.40
2.30
91.30%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-230.40
-75.50
-205.17%
Operating Profit Margin (Excl OI)
-706.10%
-951.30%
24.52%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 17.47% vs 37.68% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -205.17% vs 77.81% in Dec 2023

stock-summaryCompany CV
About Smart Eye AB stock-summary
stock-summary
Smart Eye AB
Pharmaceuticals & Biotechnology
Smart Eye AB (publ) is a Sweden-based company engaged in the machine vision system development. The Company focuses on designing a real-time eyelid and head tracking technology. The Company's activities are divided into two areas: Applied solutions and Research instruments. The Applied solutions area offers tracking technology for automotive industry, including AntiSleep, an integrated camera and software, which measures driver head pose, gaze direction and eyelid closure, and Blackbird, a compact camera system for tracking and measuring human eye and head movements. The Research instruments area provides equipment for tracking, measuring and analyzing human eye movements in various industries, such as aerospace, aviation, psychology, communication, neuroscience, medicine and clinical research.
Company Coordinates stock-summary
Company Details
Forsta Langgatan 28B , GOTEBORG None : 413 27
stock-summary
Tel: 46 31 606160
stock-summary
Registrar Details